分析妊娠期糖尿病临床规范治疗对母婴结局的改善

Analysis of Clinical Standard Treatment of Gestational Diabetes in Improving Maternal and Infant Outcomes

目的针对糖尿病妊娠期患者,实施规范化的临床治疗,分析其对母婴结局的改善情况。方法选择2017年12月—2020年12月在该院接受治疗的100例妊娠期糖尿病患者,随机均分为观察组与对照组,两组患者均接受常规产前检查,及时密切关注患者各项生命体征,予以患者充分健康宣教等常规治疗措施。观察组患者以此为基础,实施规范化治疗,比较两组患者的临床治疗效果与母婴改善情况。结果比较两组患者的顺产率,观察组为60.0%,对照组为20.0%,观察组显著高于对照组,差异有统计学意义(P<0.05);观察组的剖宫产率为30.0%,对照组为70.0%,观察组显著低于对照组,差异有统计学意义(P<0.05);观察组患者与新生儿并发症发生率显著低于对照组,差异有统计学意义(P<0.001)。结论针对妊娠期的糖尿病患者而言,对母婴结局的影响较大,可以通过规范化的治疗来提高患者的自然分娩率,降低患者与新生儿不良反应的发生率,进而实现改善母婴结局的目的,值得临床推广使用。

Objective To implement standardized clinical treatment for patients with diabetes during pregnancy and analyze the improvement of maternal and infant outcomes.Methods A total of 100 patients with gestational diabetes who received treatment in the hospital from December 2017 to December 2020 were randomly divided into observation group and control group.Both groups of patients received routine prenatal check-ups,paid close attention to the vital signs of the patients in time,provide patients with adequate health education and other conventional treatment measures.Observation group patients implemented standardized treatment based on this,and compared the clinical treatment effect of the two groups of patients and the improvement of mother and infant.Results Comparison of the normal delivery rate of the two groups of patients,the observation group was 60.0%,the control group was 20.0%,the observation group was significantly higher than the control group,the difference was statistically significant(P<0.05);the cesarean section rate of the observation group was 30.0%,the control group was 70.0%,the observation group was significantly lower than the control group,the difference was statistically significant(P<0.05);the incidence of complications of patients and newborns in the observation group was significantly lower than that of the control group,and the difference was statistically significant(P<0.001).Conclusion For gestational diabetes patients,it has a greater impact on maternal and infant outcomes.Standardized treatment can be used to increase the patient’s natural delivery rate,reduce the incidence of adverse reactions between patients and newborns,and achieve improved maternal and infant outcome’s purpose,it is worthy of clinical promotion and use.